Logos Global Management LP Ikena Oncology, Inc. Transaction History

Logos Global Management LP

  • $756 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$3.23 - $7.4 $575,847 - $1.32 Million
-178,281 Closed
0 $0
Q1 2022

May 16, 2022
SELL
$5.61 - $13.85 $682,018 - $1.68 Million
-121,572 Reduced 40.54%
178,281 $1.09 Million
Q2 2021

Aug 16, 2021
SELL
$13.27 - $26.0 $1.59 Million - $3.12 Million
-120,000 Reduced 28.58%
299,853 $4.21 Million
Q1 2021

May 17, 2021
BUY
$25.6 - $32.0 $10.7 Million - $13.4 Million
419,853 New
419,853 $11.9 Million

Others Institutions Holding IKNA

# of Institutions
61
Shares Held
30.6M
Call Options Held
0
Put Options Held
0
View Full List

About Ikena Oncology, Inc.

IKNA Quotes by TradingView
  • Ticker IKNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,257,500
  • Market Cap $55.5M
  • Description
  • Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcription factor in the Hippo signaling pathway. I...
More about IKNA
Track This Portfolio

Track Logos Global Management LP Portfolio

Follow Logos Global Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Logos Global Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Logos Global Management LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email